DFCM
BPMC

Dark Forest Capital Management’s Blueprint Medicines BPMC Stock Holding History

Dark Forest Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,261
Closed -$908K – 1202
2025
Q1 		$908K Buy
10,261
+1,682
+20% +$164K 0.04% 735
2024
Q4 		$748K Sell
8,579
-1,769
-17% -$162K 0.11% 263
2024
Q3 		$957K Buy
+10,348
New +$1.03M 0.12% 181
2023
Q2 		– Sell
-1,400
Closed -$63K – 1062
2023
Q1 		$63K Buy
+1,400
New +$63.1K 0.02% 794
2022
Q4 		– Sell
-733
Closed -$48K – 1169
2022
Q3 		$48K Buy
+733
New +$47.1K 0.01% 524
2022
Q1 		– Sell
-53
Closed -$6K – 1305
2021
Q4 		$6K Sell
53
-2,078
-98% -$217K ﹤0.01% 1085
2021
Q3 		$219K Buy
2,131
+1,908
+856% +$178K 0.08% 216
2021
Q2 		$20K Buy
+223
New +$20.4K 0.01% 565

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dark Forest Capital Management's BPMC Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 10,261 shares — an estimated $908K sold.

Dark Forest Capital Management first reported a position in BPMC in Q2 2021 and held it in 8 quarters. The position peaked at $957K in Q3 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Dark Forest Capital Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 10,261 Blueprint Medicines shares in Q2 2025, an estimated $908K.
  • Dark Forest Capital Management first reported a position in Blueprint Medicines in Q2 2021 and held it in 8 quarters.
  • Dark Forest Capital Management's Blueprint Medicines position peaked at $957K in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.